Pershing, Valeant Agree To $290M Deal Ending Allergan Suits
Hedge fund Pershing Square and Valeant Pharmaceuticals have reached a $290 million preliminary agreement to settle two investor suits in California federal court accusing them of an insider trading scheme in...To view the full article, register now.
Already a subscriber? Click here to view full article